Skip to main content
SCI logo

SCI — Investor Relations & Filings

Ticker · 4119 ISIN · TW0004119003 TW Manufacturing
Open in API
Filings indexed 1,697 across all filing types
Latest filing 2022-08-09 Major Shareholding Noti…
Country TW Taiwan
Listing TW 4119

About SCI

www.sci-pharmtech.com.tw

SCI Pharmtech, Inc. specializes in the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. Established in 1987 and originally founded by the Swiss Siegfried Group, the company provides high-quality chemical solutions and custom manufacturing services to leading global pharmaceutical corporations across Europe, North America, and Japan. Its core operations encompass advanced chemical synthesis, process optimization, and large-scale production within GMP-compliant facilities. With a robust R&D infrastructure including specialized laboratories and pilot plants, the company delivers technical excellence in complex chemical processing. SCI Pharmtech maintains a strong focus on quality assurance and international regulatory compliance, positioning itself as a reliable partner for the global healthcare and life sciences sectors.

Recent filings

Filing Released Lang Actions
110年年報及股東會資料 — 2022_4119_20220621F17.pdf
Major Shareholding Notification Classification · 95% confidence The document contains detailed information about the top ten shareholders, their shareholdings, and their relationships, including familial and related party connections. This type of disclosure is typical of a Major Shareholding Notification, which reports changes or details about significant share ownership levels and relationships among major shareholders. There is no indication of financial statements, management discussion, or other report types. The document is also relatively short and focused solely on shareholding details, fitting the Major Shareholding Notification category.
2022-08-09 Chinese
110年年報及股東會資料 — 2021_4119_20220621FE4.pdf
Annual Report Classification · 100% confidence The document is titled '2021 Annual Report' for SCI Pharmtech, Inc. It contains detailed sections typical of an annual report, including a letter to shareholders, company profile, corporate governance report, capital overview, operational highlights, financial information with audited consolidated financial reports, and a review of financial conditions and risk management. The length is substantial (15,000 characters), and it includes comprehensive financial data and analysis for the fiscal year 2021. There is no indication that this is merely an announcement or a summary notice; rather, it is the full annual report itself. Therefore, the appropriate classification is Annual Report (10-K).
2022-08-09 Chinese
110年年報及股東會資料 — 2021_4119_20220621F04.pdf
Annual Report Classification · 95% confidence The document is lengthy (15,000 characters) and contains detailed financial data, including tables with figures for different fiscal years (e.g., 110 and 111, which correspond to Taiwanese calendar years). It includes comprehensive financial performance data, operational details, and other extensive information typical of a full annual report. The presence of detailed financial statements and analysis indicates this is not a mere announcement or summary. The document also references the fiscal year and includes various financial metrics and operational data, consistent with an Annual Report (10-K equivalent). There is no indication that this is a certification, proxy, or other specific filing type. Therefore, the document is best classified as an Annual Report (10-K).
2022-08-09 Chinese
110年年報及股東會資料 — 2022_4119_20220621FE2.pdf
AGM Information Classification · 95% confidence The document is titled 'Handbook for the 2022 Annual Meeting of Shareholders' and includes detailed agenda items typical of an Annual General Meeting (AGM), such as reports on compensation, operating results, election of directors, approval of amendments to articles, and recognition of financial statements. It contains extensive attachments including the Annual Business Report, Independent Auditors' Report, Audit Committee's Review Report, and Consolidated Financial Statements for 2021. The document is comprehensive and lengthy (15,000 characters), indicating it is the actual meeting materials rather than a brief announcement. The content aligns with materials typically shared at an AGM, including procedural details, reports, and proposals for shareholder approval. Therefore, the document fits the category of AGM Information (AGM-R) rather than an Annual Report (10-K) or other categories. The presence of detailed meeting agenda, reports, and attachments confirms this classification with high confidence.
2022-08-09 Chinese
110年年報及股東會資料 — 2022_4119_20220621F13.pdf
AGM Information Classification · 95% confidence The document is titled as materials related to the Annual General Meeting (AGM) of the company, including agenda items such as reports on employee and director remuneration, business reports, audit committee reports, election of directors, amendments to company bylaws, and other shareholder meeting matters. It contains detailed proposals, explanations, and requests for shareholder approval, which are typical contents of AGM materials. The document length is 3240 characters, which is relatively short and consistent with meeting materials rather than a full annual report or financial statements. The presence of agenda items, voting proposals, and explanations aligns with the definition of AGM Information (AGM-R).
2022-08-09 Chinese
110年年報及股東會資料 — 2022_4119_20220621F02.pdf
Annual Report Classification · 95% confidence The document is in Russian and contains extensive financial data, tables, and detailed sections typical of a comprehensive financial report. It references fiscal periods (e.g., 110, 111) and includes financial metrics, operational data, and compliance information such as GMP and ISO certifications. The length is about 15,000 characters, indicating a full report rather than a brief announcement. There is no indication that this is a transcript, a voting result, or a short announcement. The detailed financial and operational data, along with the structure, strongly suggest this is an Annual Report (10-K equivalent) for the company SCI PHARMTECH, INC.
2022-08-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.